Stage‐specific skeletal and visceral defects of the IKr‐blocker almokalant: Further evidence for teratogenicity via a hypoxia‐related mechanism
- 19 October 2001
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 64 (6) , 292-300
Abstract
Background: As a class effect, potent IKr‐blockers have been shown to induce stage‐specific external malformations. The aim of this study was to investigate whether IKr‐blockers also induce stage‐specific visceral and skeletal defects and to further elucidate a proposed arrhythmia–hypoxia hypothesis.Methods: Single oral doses of the selective IKr‐blocker almokalant (ALM) 25–150 μmol/kg, 7–14 dams/group, were given to Sprague‐Dawley rats on gestation days (GD) 10–14, and the fetuses were examined for malformations on GD 21. One group was pretreated with the spin‐trapping agent, α‐phenyl‐N‐t‐butylnitrone (PBN), given intraperitoneally 1 hr before ALM on GD 11.Results: Cardiac ventricular septum defects and vascular malformations were observed after dosing on GD 10–11 and, to a lesser degree, on GD 12–13. Urogenital defects, absence/malposition of the postcaval lung lobe, and attenuated diaphragm were observed mainly on GD 10–11. Skeletal examination showed a high incidence of vertebral abnormalities on thoracic level on GD 10, on lower thoracic to caudal level on GD 11, and sternebral defects were observed all days. On GD 13 brachy‐, oligo‐, and syndactyly of the forepaw were induced, and of the hindpaw on GD 14. PBN reduced the incidence of both visceral and skeletal defects.Conclusions: The stage specificity of observed visceral and skeletal defects correlates well with what has been reported in the literature after temporary interruption of oxygen supply during the same stages of development. The protective effect by PBN present further evidence that the teratogenicity of potent IKr‐blockers is related to induction of hypoxia– reoxygenation injury due to embryonic cardiac arrhythmia. Teratology 64:292–300, 2001.Keywords
This publication has 25 references indexed in Scilit:
- Phenytoin‐induced cleft palate: Evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier k+ channels resulting in hypoxia–reoxygenation damageTeratology, 2001
- Developmental Toxicity in the Pregnant Rabbit by theClass III Antiarrhythmic Drug SotalolBasic & Clinical Pharmacology & Toxicology, 2001
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Teratogenic potential of almokalant, dofetilide, andd-sotalol: Drugs with potassium channel blocking activityTeratology, 1996
- Effects of the class III Antiarrhythmic, Dofetilide (UK‐68,798) on the heart rate of midgestation rat embryos, in vitroTeratology, 1994
- Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalantCardiovascular Research, 1994
- Fetal pathology in rats following uterine‐vessel clamping on day 14 of gestationTeratology, 1974
- A rapid method for detecting malformations in rat fetusesJournal of Morphology, 1969
- The effect of uterine vascular clamping on the development of rat embryos three to fourteen days oldJournal of Morphology, 1964
- Influence of Currents on Form of SpongesScience, 1960